Funded Projects

Since 2006, the Phospholipid Research Center has been funding research into phospholipid excipients in drugs

Drug Delivery, ParenteralInvestigation and preparation of incretin conjugated nanoemulsions as targeted drug delivery systems

Univ.-Prof. Dr. Andreas Zimmer – University Graz, Austria

Drug Delivery, ParenteralLipid nanovectors to use non-coding RNA oligonucleotides in glioblastoma in combination with standard therapy – part II

Prof. Dr. G. De Rosa, University Frederico II Naples/Italy

Drug Delivery, ParenteralTargeted liposomal drug delivery to pediatric sarcomas: beyond the EPR effect

PD Dr. M. Bernasconi, University of Bern/Switzerland

Drug Delivery, ParenteralBioactive liposomes for the treatment of Non-Alcoholic SteatoHepatitis (NASH)

Assist.Prof. Dr. R. Bansal, University Twente/The Netherlands

Drug Delivery, ParenteralCo-amorphous drug-lecithin systems – bridging the gap between amorphous solid disperions and lipid based drug delivery

Prof. Dr. Dr. h.c. Th. Rades, University of Copenhagen/Denmark

Drug Delivery, OralEnabling oral delivery of peptides by designing phospholipid complexes for self-emulsifying drug delivery systems

Prof. Dr. A. Müllertz, University of Copenhagen/Denmark

Drug Delivery, OralImproving nano-particulate carriers for oral drug delivery using archaeal tetraether lipids from novel sources

Assoc.Prof. Dr. A. Treusch, University of Southern Denmark/Denmark

Drug Delivery, ParenteralLipodisks for dual delivery of chemothereptuic drugs and anticancer peptides

Prof. Dr. K. Edwards, Uppsala University/Sweden

Drug Delivery, OralOral mixed micelle formulations – a novel phospholipid-based platform for safe and effective pediatric drug delivery

Prof. Dr. S. Klein, University of Greifswald/Germany

Drug Delivery, OralDevelopment of phospholipid based depot antimalarial tablets of azadirachta indica leaf extract and artemether/lumefantrine for oral delivery

Prof. Dr. A. A. Attama, University of Nigeria/Africa